Cho B, Kim J, Jang Y
Vaccines (Basel). 2024; 12(4).
PMID: 38675823
PMC: 11053661.
DOI: 10.3390/vaccines12040441.
Buhre J, Pongracz T, Kunsting I, Lixenfeld A, Wang W, Nouta J
Front Immunol. 2023; 13:1020844.
PMID: 36713457
PMC: 9877300.
DOI: 10.3389/fimmu.2022.1020844.
Ghasemi A, Wang S, Sahay B, Abbott J, Curtiss 3rd R
Front Immunol. 2022; 13:1034683.
PMID: 36466847
PMC: 9716130.
DOI: 10.3389/fimmu.2022.1034683.
Jawalagatti V, Kirthika P, Lee J
Front Immunol. 2022; 13:884862.
PMID: 35592330
PMC: 9110646.
DOI: 10.3389/fimmu.2022.884862.
Jawalagatti V, Kirthika P, Hewawaduge C, Park J, Yang M, Oh B
Front Immunol. 2022; 13:811802.
PMID: 35250985
PMC: 8888445.
DOI: 10.3389/fimmu.2022.811802.
Bacteria-enabled oral delivery of a replicon-based mRNA vaccine candidate protects against ancestral and delta variant SARS-CoV-2.
Jawalagatti V, Kirthika P, Hewawaduge C, Yang M, Park J, Oh B
Mol Ther. 2022; 30(5):1926-1940.
PMID: 35123065
PMC: 8810265.
DOI: 10.1016/j.ymthe.2022.01.042.
Eradication of Intracellular Salmonella Typhimurium by Polyplexes of Acid-Transforming Chitosan and Fragment DNA.
Edson J, Chu W, Porwollik S, Tran K, Iribe N, McClelland M
Macromol Biosci. 2021; 21(7):e2000408.
PMID: 33870627
PMC: 8295212.
DOI: 10.1002/mabi.202000408.
Enhanced SARS-CoV-2 neutralization by dimeric IgA.
Wang Z, Lorenzi J, Muecksch F, Finkin S, Viant C, Gaebler C
Sci Transl Med. 2020; 13(577).
PMID: 33288661
PMC: 7857415.
DOI: 10.1126/scitranslmed.abf1555.
Evaluation of the Effect of Promoter Type on the Immunogenicity of the Live Recombinant Vaccines Expressing Heat-labile Enterotoxins (LTB).
Mohit E, Nasr R, Ghazvini K, Bandegi A, Akbari Eidgahi M
Iran J Pharm Res. 2019; 17(Suppl2):98-110.
PMID: 31086557
PMC: 6447867.
Oral immunization with a novel attenuated Salmonella Typhimurium encoding influenza HA, M2e and NA antigens protects chickens against H7N9 infection.
Kim J, Hajam I, Lee J
Vet Res. 2018; 49(1):12.
PMID: 29391053
PMC: 5796500.
DOI: 10.1186/s13567-018-0509-y.
Salmonella Typhimurium, the major causative agent of foodborne illness inactivated by a phage lysis system provides effective protection against lethal challenge by induction of robust cell-mediated immune responses and activation of dendritic cells.
Won G, Lee J
Vet Res. 2017; 48(1):66.
PMID: 29070065
PMC: 5657113.
DOI: 10.1186/s13567-017-0474-x.
Mucosal vaccine delivery: Current state and a pediatric perspective.
Shakya A, Chowdhury M, Tao W, Gill H
J Control Release. 2016; 240:394-413.
PMID: 26860287
PMC: 5381653.
DOI: 10.1016/j.jconrel.2016.02.014.
Intravaginal live attenuated increase local antitumor vaccine-specific CD8 T cells.
Decrausaz L, Pythoud C, Domingos-Pereira S, Derre L, Jichlinski P, Nardelli-Haefliger D
Oncoimmunology. 2013; 2(1):e22944.
PMID: 23483225
PMC: 3583940.
DOI: 10.4161/onci.22944.
Mucosal adjuvanticity of fibronectin-binding peptide (FBP) fused with Echinococcus multilocularis tetraspanin 3: systemic and local antibody responses.
Dang Z, Feng J, Yagi K, Sugimoto C, Li W, Oku Y
PLoS Negl Trop Dis. 2012; 6(9):e1842.
PMID: 23029596
PMC: 3459843.
DOI: 10.1371/journal.pntd.0001842.
The Asd(+)-DadB(+) dual-plasmid system offers a novel means to deliver multiple protective antigens by a recombinant attenuated Salmonella vaccine.
Xin W, Wanda S, Zhang X, Santander J, Scarpellini G, Ellis K
Infect Immun. 2012; 80(10):3621-33.
PMID: 22868499
PMC: 3457550.
DOI: 10.1128/IAI.00620-12.
Attenuated Salmonella typhimurium delivering DNA vaccine encoding duck enteritis virus UL24 induced systemic and mucosal immune responses and conferred good protection against challenge.
Yu X, Jia R, Huang J, Shu B, Zhu D, Liu Q
Vet Res. 2012; 43:56.
PMID: 22770566
PMC: 3412168.
DOI: 10.1186/1297-9716-43-56.
A pilot study on developing mucosal vaccine against alveolar echinococcosis (AE) using recombinant tetraspanin 3: Vaccine efficacy and immunology.
Dang Z, Yagi K, Oku Y, Kouguchi H, Kajino K, Matsumoto J
PLoS Negl Trop Dis. 2012; 6(3):e1570.
PMID: 22479658
PMC: 3313938.
DOI: 10.1371/journal.pntd.0001570.
Live attenuated Salmonella vaccines displaying regulated delayed lysis and delayed antigen synthesis to confer protection against Mycobacterium tuberculosis.
Juarez-Rodriguez M, Yang J, Kader R, Alamuri P, Curtiss 3rd R, Clark-Curtiss J
Infect Immun. 2011; 80(2):815-31.
PMID: 22144485
PMC: 3264310.
DOI: 10.1128/IAI.05526-11.
Rectal single dose immunization of mice with Escherichia coli O157:H7 bacterial ghosts induces efficient humoral and cellular immune responses and protects against the lethal heterologous challenge.
Mayr U, Kudela P, Atrasheuskaya A, Bukin E, Ignatyev G, Lubitz W
Microb Biotechnol. 2011; 5(2):283-94.
PMID: 22103353
PMC: 3815788.
DOI: 10.1111/j.1751-7915.2011.00316.x.
A murine genital-challenge model is a sensitive measure of protective antibodies against human papillomavirus infection.
Longet S, Schiller J, Bobst M, Jichlinski P, Nardelli-Haefliger D
J Virol. 2011; 85(24):13253-9.
PMID: 21976653
PMC: 3233130.
DOI: 10.1128/JVI.06093-11.